Ohr Pharmaceutical Inc. | Ownership
Companies that own Ohr Pharmaceutical Inc.
AIGH Capital Management LLC
2,855,135
5.08%
324,667
1.62%
12/31/2017
The Vanguard Group, Inc.
1,892,636
3.37%
-26,085
0%
06/30/2018
Renaissance Technologies LLC
1,310,214
2.33%
167,905
0%
06/30/2018
Garrison, Bradford & Associates, Inc.
451,200
0.8%
-31,000
0.07%
06/30/2018
BlackRock Fund Advisors
412,666
0.73%
1,068
0%
06/30/2018
Geode Capital Management LLC
268,161
0.48%
0
0%
06/30/2018
G1 Execution Services LLC
167,429
0.3%
167,429
0%
06/30/2018
Northern Trust Investments, Inc.
139,164
0.25%
0
0%
06/30/2018
Virtu Financial BD LLC
127,286
0.23%
29,230
0%
06/30/2018
The California Public Employees Retirement System
78,800
0.14%
0
0%
06/30/2018
| Address |
800 Third Avenue
New York New York 10022
United States
|
|
Employees
|
- |
| Website |
http://www.ohrpharmaceutical.com |
| Updated |
07/08/2019 |
| Ohr Pharmaceutical, Inc. is a clinical stage company which develops novel therapies for ophthalmic diseases. Its product provides a non-invasive therapy to improve vision outcomes. The company was founded by Irach B. |
